v3.26.1
Unaudited Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2024   91,120        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options for cash (in shares)   3        
Restricted and performance stock units vested (in shares)   1,381        
Ending balance (in shares) at Jun. 30, 2025   92,504        
Stockholders' deficit, beginning of period at Dec. 31, 2024 $ (69,445) $ 9 $ 177,533 $ (7,389) $ (238,482) $ (1,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation expense     5,575      
Exercise of stock options for cash     9      
Other comprehensive income       1,218    
Net income 33,608       33,608  
Stockholders' deficit, end of period at Jun. 30, 2025 (29,035) $ 9 183,117 (6,171) (204,874) (1,116)
Beginning balance (in shares) at Mar. 31, 2025   91,351        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options for cash (in shares)   1        
Restricted and performance stock units vested (in shares)   1,152        
Ending balance (in shares) at Jun. 30, 2025   92,504        
Stockholders' deficit, beginning of period at Mar. 31, 2025 (63,696) $ 9 180,241 (7,698) (235,132) (1,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation expense     2,873      
Exercise of stock options for cash     3      
Other comprehensive income       1,527    
Net income 30,258       30,258  
Stockholders' deficit, end of period at Jun. 30, 2025 $ (29,035) $ 9 183,117 (6,171) (204,874) (1,116)
Beginning balance (in shares) at Dec. 31, 2025 91,603 91,603        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options for cash (in shares)   188        
Restricted and performance stock units vested (in shares)   1,545        
Ending balance (in shares) at Jun. 30, 2026 93,336 93,336        
Stockholders' deficit, beginning of period at Dec. 31, 2025 $ (27,029) $ 9 181,075 (5,613) (201,384) (1,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation expense     5,321      
Exercise of stock options for cash     511      
Other comprehensive income       770    
Net income 3,759       3,759  
Stockholders' deficit, end of period at Jun. 30, 2026 $ (16,668) $ 9 186,907 (4,843) (197,625) (1,116)
Beginning balance (in shares) at Mar. 31, 2026   92,133        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options for cash (in shares)   64        
Restricted and performance stock units vested (in shares)   1,139        
Ending balance (in shares) at Jun. 30, 2026 93,336 93,336        
Stockholders' deficit, beginning of period at Mar. 31, 2026 $ (22,566) $ 9 184,073 (5,509) (200,023) (1,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation expense     2,660      
Exercise of stock options for cash     174      
Other comprehensive income       666    
Net income 2,398       2,398  
Stockholders' deficit, end of period at Jun. 30, 2026 $ (16,668) $ 9 $ 186,907 $ (4,843) $ (197,625) $ (1,116)